✦ LIBER ✦

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

✍ Scribed by Dean J Kereiakes; Thomas M Broderick; Eli M Roth; David Whang; Thomas Shimshak; John Paul Runyon; Charles Hattemer; John Schneider; Pam Lacock; Michele Mueller; Charles W Abbottsmith

Book ID: 113980720
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 454 KB
Volume: 84
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(99)00321-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suboptimal inhibition of platelet aggreg

Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris

✍ Daniel Soffer; Issam Moussa; Murat Karatepe; Kishore J. Harjai; Judith Boura; Si 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Comparison of degree of platelet inhibit

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention

✍ Howard C. Herrmann; Tomasz A. Swierkosz; Shiv Kapoor; Danielle C. Tardiff; Peter 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Incidence and time course of thrombocyto

Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention

✍ Ibrahim E. Fahdi; Jorge F. Saucedo; Thomas Hennebry; Mohammad Ghani; Saihari Sad 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 94 KB

A comparative study of light transmissio

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

✍ Daniel I. Simon; Christopher B. Liu; Peter Ganz; James M. Kirshenbaum; Robert N. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Inhibition of Platelet Aggregation With

Inhibition of Platelet Aggregation With Eptifibatide, Bivalirudin, and Heparin in Patients Undergoing Percutaneous Coronary Intervention Receiving Clopidogrel Pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel With Or Without INtegrilin [DEACON] Study)

✍ Jorge F. Saucedo; Wady Aude; Rebecca Pacheco; Brett Thorn; Zakaria Matin; Khawaj 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB